Skip to main content

16-04-2021 | Oncology | News | Article


ESMO issues recommendations for SCLC management

Author: Shreeya Nanda

medwireNews: ESMO has released Clinical Practice Guidelines to aid the management of patients with small-cell lung cancer (SCLC).

The document provides key recommendations on all aspects of patient management, from diagnosis and staging to treatment, follow-up, and survivorship. The guideline authors also propose treatment algorithms for use in the limited-stage (stage I–III eligible for curative treatment), extensive-stage (stage IV or stage III disease not eligible for curative treatment), and recurrent settings.

The evidence-based guidelines, published in the Annals of Oncology, were developed by a multidisciplinary group of experts, who adhered to ESMO’s standard operating procedure for Clinical Practice Guidelines.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

Ann Oncol 2021; doi:10.1016/j.annonc.2021.03.207

Related topics

See the research in context now

with trial summaries, expert opinion and congress coverage